Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Allergan Names CFO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Allergan Names CFO

Hindman succeeds Edwards

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Jim Hindman has been named executive vice president of finance and business development, and chief financial officer at Allergan, Inc. Mr. Hindman succeeds Jeff Edwards, who after 21 years has decided to step down from the position, but will serve as a non-executive officer to facilitate the transition.
 
Mr. Hindman joined the company in 1984 and has served as senior vice president, Treasury, Risk and Investor Relations since 2002. Prior to that, he served in a variety of finance positions, including senior vice president, finance and controller, assistant corporate controller and vice president, Financial Planning and Analysis. Mr. Hindman also serves as president of The Allergan Foundation.  
 
“For more than two decades, Jeff Edwards has fully committed his considerable talents to serving Allergan and we have been exceptionally privileged to have him as a colleague,” said David E.I. Pyott, Allergan’s chairman and chief executive officer.
 
Mr. Pyott added, “We are pleased to name Jim Hindman as Allergan’s chief financial officer. Jim has been an instrumental member of our organization for many years, and particularly during the past few months, has played an important leadership role. We believe that Jim is ideally suited to assume the position of chief financial officer and we are confident that his long tenure and experience in our finance organization, together with his strong record as a leader in the Company, will be invaluable as he assumes his new role.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters